Related Experiment Video
Updated: Aug 16, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
Comparison of results in endovascular interventions for infrainguinal lesions: claudication versus critical limb
Susan M Trocciola1, Rabih Chaer, Rajeev Dayal
1Division of Vascular Surgery, New York Presbyterian Hospital, Cornell University, New York, New York 10021, USA.
Insights
Endovascular repair shows acceptable 12-month patency for chronic limb ischemia (CLI) patients, including those with claudication and critical limb ischemia. This minimally invasive approach offers limited morbidity for infrainguinal arterial disease treatment.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapies
Background:
- Chronic limb ischemia (CLI) encompasses both claudication and critical limb ischemia (CLI), necessitating effective treatment strategies.
- Endovascular repair offers a minimally invasive option for infrainguinal arterial disease.
- Comparing outcomes between claudicants and critical limb ischemia patients is crucial for treatment optimization.
Purpose of the Study:
- To analyze clinical success, patency, and limb salvage after endovascular repair in patients with CLI.
- To compare outcomes between patients presenting with claudication versus critical limb ischemia.
- To evaluate the efficacy of percutaneous techniques for infrainguinal arterial disease.
Main Methods:
- Retrospective analysis of 115 patients (mean age 71) undergoing endovascular treatment for infrainguinal arterial disease (Oct 2001-Aug 2004).
- Techniques included subintimal angioplasty and transluminal angioplasty with or without stents, classified by Transatlantic InterSociety Consensus criteria.
- Follow-up included physical exam, ankle-brachial index, and duplex ultrasound; patency assessed by Kaplan-Meier and log-rank analysis.
Main Results:
- 199 lesions treated in 121 limbs using percutaneous techniques.
- Higher rates of diabetes mellitus (67% vs 41%) and chronic renal insufficiency (22% vs 7%) in critical limb ischemia patients.
- 12-month primary patency: 85% for claudicants vs 72% for critical limb ischemia (P=0.06).
- 12-month limb salvage: 91% for critical limb ischemia patients.
- Similar morbidity and no perioperative mortality between groups.
Conclusions:
- Percutaneous endovascular intervention provides acceptable 12-month patency for both claudication and critical limb ischemia.
- The procedure demonstrates limited morbidity, making it a viable option for infrainguinal arterial disease.
- Further research may explore long-term outcomes and patient selection for optimal results.
Abstract:
This study analyzed clinical success, patency, and limb salvage after endovascular repair in patients treated for chronic limb ischemia presenting with claudication versus critical limb ischemia. Between October 2001 and August 2004, 115 patients (mean age 71) underwent endovascular treatment for infrainguinal arterial disease. Techniques included subintimal angioplasty and transluminal angioplasty with or without stents. Lesions were classified according to Transatlantic InterSociety Consensus. Follow-up (mean 11 months) included physical exam, ankle-brachial index, and duplex ultrasound. Patency rates were determined using Kaplan-Meier and compared by log-rank analysis. One hundred ninety-nine lesions were treated in 121 limbs using percutaneous techniques. Comorbidities were similar except higher rates of diabetes mellitus (67% vs 41%, P < 0.001) and chronic renal insufficiency (22% vs 7%, P < 0.05) were found in critical limb ischemia patients. Primary patency for claudicants was 100 per cent, 98 per cent, and 85 per cent at 3, 6, and 12 months and 89 per cent, 80 per cent, and 72 per cent for critical limb ischemia, respectively (P = 0.06). Limb salvage was 91 per cent at 12 months for critical limb ischemia patients. Morbidity was similar between groups, and there was no perioperative mortality. Percutaneous intervention for both claudication and critical limb ischemia provides acceptable 12 month patency with limited morbidity.
More Related Videos
08:16High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care